Journal article
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
FJ Candido-dos-Reis, H Song, EL Goode, JM Cunningham, BL Fridley, MC Larson, K Alsop, E Dicks, P Harrington, SJ Ramus, A De Fazio, G Mitchell, S Fereday, KL Bolton, C Gourley, C Michie, B Karlan, J Lester, C Walsh, I Cass Show all
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2015
Abstract
The authors thank Craig Luccarini, the staff at the Eastern Cancer Registration and Information Centre (SEARCH); Alicia Barroso, Victoria Fernandez, Miguel Urioste; Spanish Network on Rare Diseases (CIBERER); Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, the Clinical Follow-Up Study Members, and the kConFab Investigators (Peter MacCallum Cancer Center, East Melbourne, Australia: Stephen Fox, MD; Ian Campbell, PhD; Melissa Brown, PhD; Gerda Evans; Judy Kirk: Westmead Hospital, MD, PhD; Sunil Lakhani, MD; Geoff Lindeman, MD, PhD; Gillian Mitchell, MD, PhD; Kelly Phillips, MD; Melanie Price, PhD; Christobel Saund..
View full abstractGrants
Awarded by Ministero della Salute
Funding Acknowledgements
F.J. Candido-dos-Reis was funded by the Sao Paulo Research Foundation (FAPESP). The contributing studies were funded by grants from The American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN); Asociacion Espanola Contra el Cancer; Cancer Australia (509303); the Cancer Council Victoria; the Cancer Council Queensland, the Cancer Council New South Wales; Cancer Research UK (C490/A10119, C490/A10124, C490/A16561); Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. (ISCIIIRETIC RD06/0020/105, PI10/01422, PI10/31488, 2009SGR290); the European Research Council (310018, 2011294576); the Mermaid Project (Mermaid 1); Ministero della Salute of Italy "5 x 1000" fund; the National Breast Cancer Foundation of Australia; National Cancer Institute (UM1CA164920, R01CA178535, R01CA61107, U01CA71966, R01CA16056, K07CA143047, and U01CA69417, P50CA136393, R01CA122443); the NIHR Biomedical Research Centres at the University of Cambridge and the Royal Marsden NHS Foundation Trust and Institute of Cancer Research; the National Health and Medical Research Council of Australia (400281, 400413); Ovarian Cancer Research Program of the US Department of Defense (W81XWH-08-1-0684 and W81XWH-08-10685); the Peter MacCallum Cancer Centre Foundation; Scottish Funding Council; the Seventh Framework Programme of the European Union (FP/2007-2013); Swedish Cancer Society; Spanish Health Research Fund; Swedish Research Council; the University of Sydney Cancer Research Fund; and U.S. Army Medical Research and Materiel Command (DAMD17-01-1-0729).